Clinical Trials Browser

INDUSTRY × Multiple Endocrine Neoplasia Type 1 × Clear all

NCT06542237 2026-02-13

Open Label, Dose Escalation, Repeat Dose Study Evaluating YCT-529 in Healthy Males

Phase 1/2 Recruiting

Multiple Endocrine Neoplasia Type 1

NCT06620419 2026-01-27

Clinical Study of External Electrical Stimulation for Male Incontinence

Phase NA Active not recruiting

Urinary Incontinence, Multiple Endocrine Neoplasia Type 1

NCT05631795 2025-12-03

ALPINIST

Phase 4 Completed

Multiple Endocrine Neoplasia Type 1

NCT03872401 2025-11-10

VESALIUS-CV

Phase 3 Completed

12,301 enrolled

Coronary Disease, Multiple Endocrine Neoplasia Type 1

NCT05071729 2025-07-14

A Study to Learn How Elinzanetant Moves Into, Through, and Out of the Body, How Safe it is, and How it Affects the Body in Participants With Kidneys That do Not Work as Well as They Should Compared to Participants Whose Kidneys Work Normally

Phase 1 Completed

Multiple Endocrine Neoplasia Type 1, Hot Flashes

NCT02437318 2025-02-13

SOLAR-1

Phase 3 Completed

572 enrolled 22 charts 1 FDA

BreastEndocrine

Breast Neoplasms, Neoplasms, Multiple Endocrine Neoplasia Type 1

NCT06219902 2024-05-08

A Study to Learn if Elinzanetant Affects the Ability to Drive and Brain Function in Healthy Women

Phase 1 Completed

Multiple Endocrine Neoplasia Type 1, Hot Flashes

NCT02422615 2023-11-30

MONALEESA-3

Phase 3 Completed

726 enrolled 17 charts 1 FDA

BreastEndocrine

Breast Diseases, Breast Neoplasms, Neoplasms, Neoplasms by Site, Multiple Endocrine Neoplasia Type 1

NCT04845841 2023-08-09

Comparison of the Extent to Which the Drug Given as Two Different Capsule Sizes Becomes Available to the Body

Phase 1 Completed

Multiple Endocrine Neoplasia Type 1

NCT04889287 2023-08-09

A Study to Learn How Much Rosuvastatin Gets Into the Blood When Taken With or Without Elinzanetant and to Learn About the Safety of Elinzanetant in Healthy Participants

Phase 1 Completed

Multiple Endocrine Neoplasia Type 1

NCT05481528 2023-05-09

A Study to Learn How Safe the Study Treatment Elinzanetant is and How it Moves Into, Through and Out of the Body When Given as Single Increasing Doses That Are Higher Than Normally Used Compared to Placebo and Moxifloxacin in Healthy Participants

Phase 1 Completed

Multiple Endocrine Neoplasia Type 1, Hot Flashes

NCT02753686 2023-02-15

Treat ER+ight

Neoplasm Metastasis, Multiple Endocrine Neoplasia Type 1

NCT05351892 2022-07-19

A Study to Learn More About How Much of the Study Treatment Elinzanetant (or BAY3427080) Gets Absorbed, How Safe it is and How it Affects the Body in Healthy Female and Male Participants

Phase 1 Completed

Multiple Endocrine Neoplasia Type 1, Hot Flashes

NCT04981431 2022-03-29

A Study to Learn How Safe Elinzanetant is, How it Affects the Body, and How it Moves Into, Through and Out of the Body After Single and Multiple Doses in Japanese Healthy Female Adults

Phase 1 Completed

Multiple Endocrine Neoplasia Type 1

NCT04903821 2022-03-24

A Study to Learn How Different Levels of Decreased Liver Function Influence Blood Levels of Elinzanetant Compared to Normal Liver Function in Male and Female Participants

Phase 1 Completed

Multiple Endocrine Neoplasia Type 1

NCT05061563 2022-03-17

A Study to Learn How a Proton Pump Inhibitor Affects the Way Elinzanetant (BAY 3427080) Moves Into, Through and Out of the Body, and How Much of it Gets Absorbed by the Body When Taken as a Single and Small Radioactive Dose in Healthy Adults

Phase 1 Completed

Multiple Endocrine Neoplasia Type 1, Hot Flashes

NCT05028608 2022-02-25

A Study to Learn What Happens to Elinzanetant in the Body When Taken With or Without Carbamazepine, and How Safe it is in Healthy Men and Women Aged 18 to 60 Years.

Phase 1 Completed

Multiple Endocrine Neoplasia Type 1

NCT03050398 2020-05-28

A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib

Phase 3 Terminated

8 enrolled 4 charts

BreastEndocrine

Breast Neoplasms, Multiple Endocrine Neoplasia Type 1

NCT00980174 2018-10-17

Study to Compare the Efficacy and Safety of DenosumAb Versus Placebo in Males With Osteoporosis

Phase 3 Completed

242 enrolled 19 charts

Bone Diseases, Metabolic, Osteoporosis, Multiple Endocrine Neoplasia Type 1

NCT01030939 2017-06-20

Study to Investigate Safety, Tolerability, Pharmacokinetics and Cardiac Function After Repeat Doses of SB-649868 in Healthy-volunteers

Phase 1 Completed

Sleep Wake Disorders, Multiple Endocrine Neoplasia Type 1

NCT01852487 2013-05-13

Effect of Pumpkin Seed Oil on Hair Growth in Men With Androgenetic Alopecia

Phase NA Completed

Alopecia, Multiple Endocrine Neoplasia Type 1

NCT01245413 2013-01-01

Controlled Randomized Study With Athena Base Plate Versus SenSura Base Plate on Perspiring Skin

Phase NA Completed

32 enrolled 4 charts

Multiple Endocrine Neoplasia Type 1